Diabetes

Apr 18, 2010

The primary study (glycemia) in the ACCORD trial was terminated early after concerns emerged regarding the safety of a very aggressive treatment strategy.  This landmark trial has led many to re-examine the risks and benefits of intensive glycemic control in patients with type 2 diabetes. 

Comments: 6

Pages